Intravitreal Cidofovir (HPMPC) Treatment of Cytomegalovirus Retinitis in Patients with Acquired Immune Deficiency Syndrome
- 1 April 1995
- journal article
- clinical trial
- Published by Elsevier BV in Ophthalmology
- Vol. 102 (4), 533-543
- https://doi.org/10.1016/s0161-6420(95)30985-2
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Treatment of cytomegalovirus retinitis with intravitreal injection of liposome encapsulated ganciclovir in a patient with AIDS.British Journal of Ophthalmology, 1994
- Therapeutic potential of HPMPC as an antiviral drugReviews in Medical Virology, 1993
- Evaluation of HPMPC therapy for primary and recurrent genital herpes in mice and guinea pigsAntiviral Research, 1993
- Mortality in Patients with the Acquired Immunodeficiency Syndrome Treated with either Foscarnet or Ganciclovir for Cytomegalovirus RetinitisNew England Journal of Medicine, 1992
- Comparative activity of selected antiviral compounds against clinical isolates of human cytomegalovirusEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) against guinea pig cytomegalovirus infection in cultured cells and in guinea pigsAntiviral Research, 1990
- Useful adjuncts for vitreoretinal surgery.British Journal of Ophthalmology, 1989
- Intravenous and intraocular ganciclovir for CMV retinitis in patients with AIDS or chemotherapeutic immunosuppression.British Journal of Ophthalmology, 1988
- A novel selective broad-spectrum anti-DNA virus agentNature, 1986
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958